Nektr Technologies

Nektr Technologies is a Singapore-based biotechnology company that has developed a proprietary synthetic polymer platform called Nektr-P. This platform is engineered to mimic the physical and chemical properties of viruses, allowing for the precise delivery of antigens and adjuvants to stimulate potent immune responses. The company is primarily focused on the development of advanced cancer vaccines and therapies for infectious diseases. By utilizing its deep-tech polymer expertise, Nektr aims to create more effective and stable immunotherapies that can be easily manufactured and deployed globally. The company originated as a spin-off from the National University of Singapore's Graduate Research Innovation Programme. Its technology seeks to overcome the limitations of current lipid nanoparticle and viral vector delivery systems.